Bordetella pertussis, the etiological agent of whooping cough, synthesizes a calmodulin-sensitive adenylate cyclase that is suspected to play a major role in the virulence of this bacterium. We show that adenylate cyclase synthesized as a 200-kilodalton protein is the product of the cyaA gene and that various virulent Bordetella species secrete this high-molecular-weight polypeptide without apparent proteolytic processing. When submitted to trypsin digestion, the 200-kilodalton protein was converted to a stable 45-to 50-kilodalton species. This corresponds to the size of the enzyme previously purffied from a culture supernatant. The molecular heterogeneity reported for the various identified forms of adenylate cyclase could therefore result in part from proteolytic degradation or molecular aggregation of the major 200-kilodalton form of the enzyme.
Bordetella pertussis, the causative agent of whooping cough, produces a variety of factors responsible for its virulence (24) . One of them, a calmodulin-activated adenylate cyclase (AC) (26) , has been shown to invade eucaryotic cells and to provoke damage by disturbing intracellular cyclic AMP metabolism (4) . The cloning and sequencing of the structural gene, cyaA, revealed a single open reading frame of 1,706 codons (7) encoding a high-molecular-mass protein of approximately 200 kilodaltons (kDa).
Both whole-cell extracts and culture supernatants have been shown to exhibit AC activity (11) . Intra-and extracellular enzymes have been purified by several groups and revealed a variety of forms ranging from 45 to 700 kDa (10, 12, 15, 22) . Recently, Rogel et al. (20) and Masure and Storm (17) identified in bacterial extracts a 200-kDa protein that cross-reacted with antibodies obtained by immunizing rabbits with the low-molecular-mass (45-kDa) form of the enzyme. It was suggested that the 200-kDa polypeptide large precursor of the AC is proteolytically processed during the secretion of the enzyme into smaller forms of 45 to 50 kDa (17, 20) . However, neither the process governing secretion of AC into the external medium nor the relationship between the different molecular forms of the enzyme has been established. In this study, we report direct evidence that the cyaA gene product is a 200-kDa protein that is secreted into the culture medium with no apparent processing.
MATERIALS AND METHODS Chemicals. Tolylsulfonyl phenylalanyl chloromethyl ketone-trypsin, soybean trypsin inhibitor, and calmodulinagarose were from Sigma Chemical Co. (St. Louis, Mo.). Urea was a product of Schwarz/Mann, Orangeburg, N.Y. Alkaline phosphatase labeled with anti-rabbit immunoglobulin was purchased from Promega Biotec Co. (Madison, Wis.). Azidocalmodulin (azido-CaM) was synthesized and iodinated as described previously (14) . [1251] azido-CaM was stored at -20°C, protected from light.
Analytical procedures. AC activity was determined in the presence of 0.1 ,uM CaM as described previously (15 using a single-column procedure. Protein concentrations were measured as described by Bradford (2) . Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed as described by Laemmli (16) .
Bacterial strains and growth conditions. Bacterial strains used in this study are listed in Table 1 . Virulent strains of B.
pertussis are characterized by the following phenotypes: filamentous hemagglutinin (Fha), pertussis toxin (Ptx) synthesis, extracellular AC activity, and hemolytic activity of isolated bacterial clones on blood agar (24) . Bacteria were grown on Bordet Gengou (Difco Laboratories, Detroit, Mich.) plates supplemented with 15% sheep blood and subcultured in liquid Stainer and Scholte (SS) medium (23) sterilized on a 0.22-pm pore-size Sterivex filter (Millipore Corp., Bedford, Mass.). Cells from 20 ml of exponentially growing cultures were used to inoculate 230 ml of SS medium, and growth was carried out for 20 to 40 h at 36°C under aeration. C-mode cells, characterized by a loss of virulence factors, were obtained by growth in SS medium containing an excess of nicotinic acid (13) .
Plasmids and constructions of strains. The plasmids used in this work are listed in Table 1 , and their construction scheme is shown in Fig. 1 . Plasmid pHSP6 is a pLA2917 (1) derivative containing a Sau3A DNA fragment harboring the ampicillin resistance gene from pBR322 cloned into the BglII site. Plasmid pDIA5209 is a pLA2917 derivative containing an NsiI DNA fragment harboring the entire cya operon and cloned into the PstI site. Plasmid pDIA5214 is a pLA2917 derivative containing the 10-kilobase BamHI fragment as in pDIA5209 cloned into the BglII site. Plasmid pHSP3 is a pDIA5214 derivative obtained after internal deletion of the 9.5-kilobase EcoRI fragment. Plasmid pHSP5 is a pDIA5214 derivative obtained after internal deletion of the 6.5-kilobase XhoI fragment. All of these plasmids were introduced into strain B. pertussis 348 by bacterial mating as previously described (8) .
Preparation of bacterial extracts and detection of AC on Western immunoblots. The cell pellet from a 10-ml culture grown for 40 h was stirred with 0.8 ml of 5 M urea [wt/vol] SDS, 0.1% bromophenol blue) and electrophoresed. When samples of crude supernatants were tested, the proteinaceous material present in these supernatants was precipitated with trichloroacetic acid (10% final concentration) at 0°C for 1 h. The precipitated material was harvested by centrifugation (10,000 x g for 15 min at 4°C), and the pellet was suspended in sample buffer. Proteins were transferred from polyacrylamide gels to nitrocellulose sheets and incubated with rabbit polyclonal immune sera directed against the 45-kDa secreted AC of B. pertussis (18) . The sera were depleted of contamining antibodies by incubating them with crude bacterial extract of an avirulent strain of Bordetella bronchiseptica, which is a common pathogen of rabbits. The immunochemical detection was performed with 251I-labeled protein A (18) or with alkaline phosphatase-labeled antirabbit immunoglobulins (9) .
Purification of the 200-kDa form (AC200) of AC. Four grams of virulent B. pertussis 18323 were stirred with 25 ml of 5 M urea in buffer A for 1 h at room temperature and then centrifuged at 13,000 x g for 20 min. The supernatant was diluted four times with buffer A and adsorbed overnight at 4°C onto 3 ml of CaM-agarose. The gel was washed with buffer A and then with 0.5 M NaCl in buffer A. Bound proteins were eluted with 8 M urea in buffer A. The purified enzyme was extensively dialyzed against buffer A and stored at -20°C. About 300 U (corresponding to about 750 ,ug of protein) of pure AC200 was obtained, with a mean recovery of 30%.
Photoaffinity labeling. Purified AC200 (2 U) and 70 nM
[1251]azido-CaM in 100 ,ul of buffer A were irradiated at 4°C
for 2 min with a longwave mercury lamp (mineral light UVSL 58 without a screen) positioned at 5 cm from the sample. Limited proteolysis with trypsin. Two units of purified intracellular 200-kDa AC in 100 ,ul of buffer A was supplemented with 1 FxM CaM and then incubated at 4°C with 100 ng of tolylsulfonyl phenylalanyl chloromethyl ketone-treated trypsin. At different time intervals, 20-,ul samples were withdrawn and supplemented with 10 ,ug of soybean trypsin inhibitor. After the residual AC activity was determined, the remaining samples were subjected to 7.5% SDS-PAGE, and proteins were transferred to nitrocellulose and immunoblotted as described above. The ['25I]azido-CaM-labeled enzyme was trypsinized identically. After electrophoresis the proteins were stained with Coomassie blue, and dried gels were exposed to Kodak X-Omat AR film at -80°C with an intensifying screen.
RESULTS AND DISCUSSION Characterization of the cyaA gene product as a 200-kDa protein. Several authors (15, 20, 22 ) purified a 45-to 50-kDa form of AC. However, the predicted amino acid sequence of the cyaA gene product indicated that AC was synthesized as a 200-kDa polypeptide (8) . We wanted to know whether antibodies directed against the purified 45-kDa AC could react with a high-molecular-mass form of AC. When bacterial extracts of virulent strains (18323 and Tohama) were tested in Western blots, these antibodies recognized mainly a 200-kDa polypeptide (Fig. 2) pertussis 348 (resulting from insertion of a Tn5 transposon at the 5' end of the cyaA gene [25] ) and the 18323 phase IV B. pertussis strain and in C-mode cells, which are all devoid of AC and hemolytic activity (13, 25) . In all cases the amount of the 200-kDa protein in bacterial extracts paralleled the level of AC activity. The following three criteria were used to prove that the 200-kDa protein is indeed the cyaA gene product.
(i) The enzyme was purified by CaM-agarose chromatography from extracts of the B. pertussis 18323 strain as described in Materials and Methods. The purified preparation (specific activity, 390 U/mg of protein at saturating CaM concentration) exhibited a single band of 200 kDa on SDS-PAGE (see Fig. 4C , lane 5). Its amino acid composition was in agreement with the amino acid composition deduced from the nucleotide sequence of the cyaA gene (Table 2) .
(ii) It has been recently reported that AC and hemolytic activities could be restored in B. pertussis 348 (AC-Hly-) by complementation with plasmids carrying the complete cyaA operon (3, 8) . We extended these findings by showing that complementation with plasmid pDIA5209 resulted in the synthesis of a 200-kDa polypeptide (Fig. 3, lane 2) .
(iii) Deletions of the cyaA gene at its 3' terminus by 700 and 850 codons were expected to yield truncated AC products in the recombinant strains after transformation of B. pertussis 348 with the corresponding plasmids pHSP5 and pHSP3 (Fig. 1) . Bacterial extracts of the recombinant strains exhibited AC activity, and Western blot analysis revealed two polypeptides that cross-reacted with anti-AC antibodies of 120 kDA [B. pertussis 348(pHSP5)] and 95 kDa [B. pertussis 348(pHSP3)], respectively (Fig. 3, lanes 3 and 4) . These results showed a parallel decrease in size of the 200-kDa AC corresponding to the size of the deletions generated in the cyaA gene.
Conversion by limited proteolysis AC200 into a 45-to 50-kDa species. The purified intracellular AC200 was exposed for different time intervals to trypsin and subsequently analysed by SDS-PAGE and Western blotting. The 200-kDa protein was cleaved in less than 1 min in a 43-kDa immuno- reactive fragment with no loss of enzymatic activity (Fig.  4A) . After further 10 min of incubation with trypsin, this 43-kDa residual fragment seemed to be resistant to proteolysis, since no appreciable degradation occurred (Fig. 4A) . In a second set of experiments the purified AC200 was cross-linked with [125I]azido-CaM and then submitted to proteolysis by trypsin. Irradiation of a mixture of AC200 and
[125I]azido-CaM yielded radioactive species with an apparent molecular mass of 210 to 220 kDa (Fig. 4B, lane 5) .
Exposure of the [125I]azido-CaM-labeled AC200 to trypsin digestion resulted in the conversion of the radioactive crosslinked product to species of 63 kDa (Fig. 4B) . Most likely the 63-kDa band corresponds to a cross-linked product of
[1251I]azido-CaM with the 43-kDa fragment, which was evidenced by Coomassie blue staining (Fig. 4C) . Recently, Gilboa-Ron et al. also reported that the 200-kDa form of AC could be cleaved by lymphocyte lysates into an active 42-kDa fragment (6) .
Identification of a high-molecular-weight form of AC in culture supernatants of B. pertussis. It has previously been suggested that the 45-kDa AC form secreted by B. pertussis is derived from proteolytic processing of a large intracellular precursor (17, 20) . This model was based only on the identification of low-molecular-weight species of AC, in partially concentrated or purified culture supernatants. We therefore focused our attention on the molecular weight forms of AC present in crude supernatants of early exponential phase cultures. A Western blot analysis of mid-log-phase Residual activity (expressed as a percentage of the initial activity on the top of each lanes) was determined for each sample. The remaining samples were subjected to 7.5% SDS-PAGE, transferred to nitrocellulose, and immunoblotted with anti-AC antibodies as described in Materials and Methods. (B and C) Purified AC200 was labeled with [125I]azido-CaM as described in Materials and Methods and exposed to digestion by trypsin at 4°C for 0 (lane 5), 1 (lane 6), 5 (lane 7), or 10 (lane 8 ) min. Residual AC activity was determined and expressed as above. The remaining samples were subjected to 7.5% SDS-PAGE, and the gels were stained with Coomassie blue (C) and exposed for autoradiography (B). The molecular weight markers as in Fig. 2 . strain to another (Table 3 ). B. pertussis 18323 produced as much as 0.25 to 0.5 ,ug of the 200-kDa protein per ml of culture supernatant. It is unlikely that this amount of extracellular protein could result from cell lysis, because it represents about 20 to 50% of the total AC synthesized by the bacteria. It can therefore be concluded that the large unprocessed form of AC is secreted into the external medium. No difference in molecular weight was observed between the intracellular enzyme and that identified in the culture supernatants (Fig. SA) . When a supernatant of the virulent 18323 B. pertussis strain was submitted to limited proteolysis with trypsin, the 200-kDa polypeptide was converted into a low-molecular-mass immunoreactive 43-to 50-kDa protein with no loss of AC activity (Fig. 5B) .
We propose that secretion of B. pertussis AC does not necessarily require proteolytic cleavage of the 200-kDa intracellular polypeptide. It seems likely that the previously purified extracellular 45-kDa AC is a degraded form of the secreted 200-kDa AC found during culture growth or results simply from the enzyme purification procedures used. In fact, growing B. pertussis in filtered sterile SS medium instead of the classical autoclaved medium (23) enhances bacterial growth and significantly delays proteolytic degradation of the 200-kDa AC form into 45-to 50-kDa AC species. This indicates that the composition of the bacterial growth medium could modify the sensitivity of the secreted 200-kDa protein to proteolytic degradation. Moreover, when bovine serum albumin was added to the culture medium, a higher yield of secreted 200-kDa polypeptide was obtained (data not shown).
Concluding remarks. In the present work, we provided direct evidence that the cyaA gene product is a 200-kDa protein that corresponds to the major intracellular form of the enzyme AC. We also showed that the 200-kDa polypeptide was secreted into the external medium of virulent strains of B. pertussis without any detectable proteolytic processing. The secretion of a large, unprocessed form of AC was also observed for B. parapertussis and B. bronchiseptica strains and is likely to be common feature of the Bordetella genus. It is probable that the molecular heterogeneity of AC purified from culture supernatants results in part from proteolytic degradation into catalytically active fragments, as has been proposed by several authors (17, 20 Fig. 1 . Purified 45-kDa AC was run as a control (lane 6). The molecular weight standards are as in Fig. 2 .
Recent studies revealed that the secretion of B. pertussis AC requires the expression of three additional genes (cyaB, cyaD, and cyaE) contiguous to the structural cyaA gene (8) . These four genes appear to form a single operon with a structure similar to that of the E. coli. hly operon. Two products of the secretion genes cyaB and cyaD show a large extent of similarity with the products of the secretion genes of E. coli alpha-hemolysin hlyB and hlyD (8) . Interestingly, E. coli alpha-hemolysin is secreted as a 110-kDa polypeptide without apparent proteolytic processing but was shown to be rapidly degraded in the culture supernatant (5) . A similar observation is reported here for B. pertussis AC and supports the hypothesis of a common secretion mechanism for this enzyme and the E. coli alpha-hemolysin.
